Merck initiates melanoma filing with FDA By: MarketWatch January 13, 2014 at 11:45 AM EST Merck has initiated a rolling submission of its Food and Drug Administration application for its treatment for patients with advanced melanoma. Read More >> Related Stocks: Bristol-Myers Squibb Macy's Merck & Co
